Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2024-02-05 Board/Management Inform…
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal notification from Wockhardt Limited to stock exchanges about an upcoming Board of Directors meeting scheduled for 14th February 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2023. The document also mentions the trading window closure related to this event. The content is an announcement of a board meeting and the intent to approve financial results, but it does not contain the financial results themselves or detailed financial data. The document length is short (1457 characters), and it serves as an intimation rather than the actual report. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or meetings of the board of directors or senior management.
2024-02-05 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification from Wockhardt Limited regarding the allotment of equity shares pursuant to the exercise of stock options under the Employee Stock Options Scheme - 2011. It includes details such as the number of shares allotted, the date of allotment, share certificate numbers, ISIN, exercise price, and confirmation that the shares rank pari-passu with existing shares. The document references compliance with SEBI regulations and provides a statement as per Regulation 10(c) of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. This is a clear announcement of a share allotment event related to employee stock options, which fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other types of filings. The document length is 4209 characters, which is relatively short and focused on the share allotment event. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2024-01-19 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st December 2023. It is a confirmation from the Registrar and Share Transfer Agent regarding dematerialisation of securities and related compliance. The document is short (3301 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory documents that do not fit other specific categories.
2024-01-09 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter from Wockhardt Limited to stock exchanges regarding a newspaper advertisement about the transfer of equity shares to the Investor Education and Protection Fund (IEPF). It includes details about the publication of the advertisement in newspapers and requests the exchanges to take the information on record. The content is an official announcement related to shareholder matters, specifically about share transfers to IEPF, which is a regulatory compliance disclosure. There is no financial data, no detailed report, no earnings information, no management discussion, or any other detailed report content. The document is not a full report but an announcement of a regulatory event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window in accordance with the company's code of conduct related to trading by designated persons. It mentions the upcoming declaration of unaudited financial results for the quarter and nine months ended December 31, 2023, but does not contain any financial data or results itself. The document is essentially an announcement related to regulatory compliance and trading restrictions prior to financial results disclosure. Given its short length (1284 characters) and nature as an announcement rather than a report, it fits best under Regulatory Filings (RNS).
2023-12-26 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the successful completion of a Phase 3 clinical study for a pharmaceutical product. It is addressed to stock exchanges and is titled as a press release. There is no detailed financial data, regulatory filing, or report attached. The content focuses on clinical trial results and company information rather than financial performance or governance. This fits the category of a general regulatory announcement or press release rather than a financial report or management discussion. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.